Decreased factor XII activity is associated with recurrent IVF-ET failure

American Journal of Reproductive Immunology

Volumn 59, Issue 4, 2008, Pages 316-322

  Matsubayashi, Hidehiko ^a,b   Sugi, Toshitaka ^a   Suzuki, Takahiro ^a   Uchida, Noa ^a   Atsumi, Haruyo ^a   Izumi, Shun Ichiro ^a   Mikami, Mikio ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY HACHIOJI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTINUCLEAR ANTIBODY; ANTITHROMBIN; AUTOANTIBODY; BLOOD CLOTTING FACTOR 12; FIBRIN DEGRADATION PRODUCT; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTHROMBIN; THROMBIN; THROMBOPLASTIN;

ADULT; AGE; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING PARAMETERS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RANK SUM TEST; RECURRENT ABORTION; TREATMENT FAILURE;

ABORTION, HABITUAL; ADULT; AGE FACTORS; AUTOANTIBODIES; EMBRYO TRANSFER; FACTOR XII DEFICIENCY; FEMALE; FERTILIZATION IN VITRO; HUMANS; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; TREATMENT FAILURE;

EID: 40949101431     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2007.00564.x     Document Type: Article

References (38)

1. Colman RW,ASchmaier AH: Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 1997; 90:3819-3843.
2. Yarovaya GA, Blokhina TB, Neshkova EA: Contact system. New concepts on activation mechanisms and bioregulatory functions. Biochemistry (Mosc) 2002; 67:13-24.
3. Halbmayer WM, Haushofer A, Schon R, Mannhalter C, Strohmer E, Baumgarten K, Fischer M: The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: Evaluation of the incidence of FXII deficiency among 300 healthy blood donors. Thromb Haemost 1994; 71:68-72.
4. Lammle B, Wuillemin WA, Huber I, Krauskopf M, Zurcher C, Pflugshaupt R, Furlan M: Thromboembolism and bleeding tendency in congenital factor XII deficiency-a study on 74 subjects from 14 Swiss families. Thromb Haemost 1991; 65:117-121.
5. Zeerleder S, Schloesser M, Redondo M, Wuillemin WA, Engel W, Furlan M, Lammle B: Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency-a study on 73 subjects from 14 Swiss families. Thromb Haemost 1999; 82:1240-1246.
6. Halbmayer WM, Mannhalter C, Feichtinger C, Rubi K, Fischer M: Factor XII (Hageman factor) deficiency: A risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction. Wien Med Wochenschr 1993; 143:43-50 (in German).
7. Tirado I, Soria JM, Mateo J, Oliver A, Souto JC, Santamaria A, Felices R, Borrell M, Fontcuberta J: Association after linkage analysis indicates that homozygosity for the 46C→T polymorphism in the F12 gene is a genetic risk factor for venous thrombosis. Thromb Haemost 2004; 91:899-904.
8. Winter M, Gallimore M, Jones DW: Should factor XII assays be included in thrombophilia screening?. Lancet 1995; 346:52.
9. McPherson RA: Thromboembolism in Hageman trait. Am J Clin Pathol 1977; 68:420-423.
10. Hellstern P, Kohler M, Schmengler K, Doenecke P, Wenzel E: Arterial and venous thrombosis and normal response to streptokinase treatment in a young patient with severe Hageman factor deficiency. Acta Haematol 1983; 69:123-126.
11. Schloesser M, Zeerleder S, Lutze G, Halbmayer WM, Hofferbert S, Hinney B, Koestering H, Lammle B, Pindur G, Thies K, Kohler M, Engel W: Mutations in the human factor XII gene. Blood 1997; 90:3967-3977.
12. Koster T, Rosendaal FR, Briet E, Vandenbroucke JP: John Hageman's factor and deep-vein thrombosis: Leiden thrombophilia Study. Br J Haematol 1994; 87:422-424.
13. Coppola R, Cristilli P, Cugno M, Ariens RA, Mari D, Mannucci PM: Measurement of activated factor XII in health and disease. Blood Coagul Fibrinolysis 1996; 7:530-535.
14. Girolami A, Simioni P, Scarano L, Girolami B, Zerbinati P: Symptomatic combined homozygous factor XII deficiency and heterozygous factor V Leiden. J Thromb Thrombolysis 2000; 9:271-275.
15. Lodi S, Isa L, Pollini E, Bravo AF, Scalvini A: Defective intrinsic fibrinolytic activity in a patient with severe factor XII-deficiency and myocardial infarction. Scand J Haematol 1984; 33:80-82.
16. Wada H, Nishioka J, Kasai Y, Kato-Nakazawa K, Abe Y, Morishita Y, Nakatani K, Nobori T: Molecular characterization of coagulation factor XII deficiency in a Japanese family. Thromb Haemost 2003; 90:59-63.
17. Braulke I, Pruggmayer M, Melloh P, Hinney B, Kostering H, Gunther E: Factor XII (Hageman) deficiency in women with habitual abortion: New subpopulation of recurrent aborters? Fertil Steril 1993; 59:98-101.
18. Schved JF, Gris JC, Neveu S, Dupaigne D, Mares P: Factor XII congenital deficiency and early spontaneous abortion. Fertil Steril 1989; 52:335-336.
19. Gris JC, Ripart-Neveu S, Maugard C, Tailland ML, Brun S, Courtieu C, Biron C, Hoffet M, Hedon B, Mares P: Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) Study. Thromb Haemost 1997; 77:1096-1103.
20. Yamada H, Kato EH, Ebina Y, Kishida T, Hoshi N, Kobashi G, Sakuragi N, Fujimoto S: Factor XII deficiency in women with recurrent miscarriage. Gynecol Obstet Invest 2000; 49:80-83.
21. Yamada H, Kato EH, Kobashi G, Ebina Y, Shimada S, Morikawa M, Yamada T, Sakuragi N, FujimotoES: Recurrent pregnancy loss: etiology of thrombophilia. Semin Thromb Hemost 2001; 27:121-129.
22. Ogasawara MS, Aoki K, Katano K, Ozaki Y, Suzumori K: Factor XII but not protein C, protein S, antithrombin III, or factor XIII is a predictor of recurrent miscarriage. Fertil Steril 2001; 75:916-919.
23. Iinuma Y, Sugiura-Ogasawara M, Makino A, Ozaki Y, Suzumori N, Suzumori K: Coagulation factor XII activity, but not an associated common genetic polymorphism (46C/T) is linked to recurrent miscarriage. Fertil Steril 2002; 77:353-356.
24. Pauer HU, Burfeind P, Kostering H, Emons G, Hinney B: Factor XII deficiency is strongly associated with primary recurrent abortions. Fertil Steril 2003; 80:590-594.
25. Matsuura T, Kobayashi T, Asahina T, Kanayama N, Terao T: Is factor XII deficiency related to recurrent miscarriage? Semin Thromb Hemost 2001; 27:115-120.
26. Matsubayashi H, Sugi T, Arai T, Kondo A, Suzuki T, Izumi S-I, McIntyre JA, Makino T: Different antiphospholipid antibody specificities are found in association with early repeated pregnancy loss versus recurrent IVF-failure patients. Am J Reprod Immunol 2001; 46:323-329.
27. Veeck LL: An Atlas of the Human Gametes and Conceptuses. New York, Parthenon Publishing, 1998.
28. Tulandi T, Al-Fozan HM: Evaluation and management of couples with recurrent pregnancy loss. In UpToDate version 15.2, (March 22 2007), BD Rose (ed). UpToDate, Waltham, MA, 2007.
29. Kitchens CS: The contact system. Arch Pathol Lab Med 2002; 126:1382-1386.
30. Kanaji T, Kanaji S, Osaki K, Kuroiwa M, Sakaguchi M, Mihara K, Niho Y, Okamura T: Identification and characterization of two novel mutations (Q421K and R123P) in congenital factor XII deficiency. Thromb Haemost 2001; 86:1409-1415.
31. Miyachi K, Fritzier MJ, Tan EM: Autoantibody to a nuclear antigen in proliferating cells. J Immunol 1978; 121:2228-2234.
32. Thiagarajan P, Pengo V, Shapiro SS: The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulant. Blood 1986; 68:869-874.
33. Carmona F, Lazaro I, Reverter JC, Tassies D, Font J, Cervera R, Balasch J: Impaired factor XIIa-dependent activation of fibrinolysis in treated antiphospholipid syndrome gestations developing late-pregnancy complications. Am J Obstet Gynecol 2006; 194:457-465.
34. Jones DW, MacKie IJ, Gallimore MJ, Winter M: Antibodies to factor XII and recurrent fetal loss in patients with the anti-phospholipid syndrome. Br J Haematol 2001; 113:550-552.
35. Jones DW, Gallimore MJ, Harris SL, Winter M: Antibodies to factor XII associated with lupus anticoagulant. Thromb Haemost 1999; 81:387-390.
36. Jones DW, Gallimore MJ, MacKie IJ, Harris SL, Winter M: Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII. Br J Haematol 2000; 110:721-726.
37. Iwaki T, Castellino FJ: Plasma levels of bradykinin are suppressed in factor XII-deficient mice. Thromb Haemost 2006; 95:1003-1010.
38. Hornstein MD, Davis OK, Massey JB, Paulson RJ, Collins JA: Antiphospholipid antibodies and in vitro fertilization success: A meta-analysis. Fertil Steril 2000; 73:330-333.